Cited by 1,301Pluripotent Stem Cells ResearchDevelopmental Biology and Gene RegulationNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

Open access

Hong, Hyenjong, Takahashi, Kazutoshi, Ichisaka, Tomoko, Aoi, Takashi, Kanagawa, Osami, Nakagawa, Masato, Okita, Keisuke, Yamanaka, Shinya·2009·Nature

DOI 10.1038/nature08235PMC PMC2917235

Open this paper in CoChat — free account

Abstract

Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse and in human. The efficiency of this process, however, is low. Pluripotency can be induced without c-Myc, but with even lower efficiency. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08235

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citation
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citation
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Self-citation
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R. K., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,732
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citation
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,056
Self-citation
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660

Show all 23 references

Sorted by citations

Items 701–800 of 1,003

In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status
Reid, P., Wilson, P., Li, Y., Marcu, L. G., Staudacher, A. H., Brown, M. P., & Bezak, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186186 · Cited by 22
MYD88 signals induce tumour-initiating cell generation through the NF-κB-HIF-1α activation cascade
Tanimura, A., Nakazato, A., & Tanaka, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-83603-4 · Cited by 22
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies
Grassi, E., Ghiandai, V., & Persani, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071455 · Cited by 23
The role of microRNAs in embryonic stem cell and induced pluripotent stem cell differentiation in male germ cells
Mahabadi, J. A., Sabzalipoor, H., Nikzad, H., Seyedhosseini, E., Enderami, S. E., Hayat, S. M. G., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27990 · Cited by 22
Visualizing Structure and Transitions for Biological Data ExplorationPreprint
Moon, K. R., van Dijk, D., Wang, Z., Burkhardt, D. B., Chen, W. S., Yim, K., van den Elzen, A. M. G., Hirn, M., Coifman, R. R., Ivanova, N. B., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155891 · Cited by 22
The crosstalk between cellular reprogramming and senescence in aging and regeneration
Chiche, A., Chen, C., & Li, H. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111005 · Cited by 21
The intricate nature of senescence in development and cell plasticity
Gal, H., Majewska, J., & Krizhanovsky, V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.01.004 · Cited by 21
Integration-free and stable expression of FVIII using a human artificial chromosome
Kurosaki, H., Hiratsuka, M., Imaoka, N., Iida, Y., Uno, N., Kazuki, Y., Ishihara, C., Yakura, Y., Mimuro, J., Sakata, Y., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.88 · Cited by 21
Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells
Chang, G., Miao, Y., Zhang, Y., Liu, S., Kou, Z., Ding, J., Chen, D., Sun, Q., & Gao, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010320 · Cited by 21
Cell fate conversion: Direct induction of hepatocyte‐like cells from fibroblasts
Ji, S., Zhang, L., & Hui, L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24380 · Cited by 21
Micro-management of pluripotent stem cells
Guo, W., Wang, X., & Wang, Y. (2014) · Protein & Cell · doi:10.1007/s13238-013-0014-z · Cited by 21
MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
Liu, L., Xu, F., Chang, C., He, Q., Wu, L., Zhang, Z., & Li, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.526 · Cited by 21
Heme oxygenase‐1 affects generation and spontaneous cardiac differentiation of induced pluripotent stem cells
Stępniewski, J., Pacholczak, T., Skrzypczyk, A., Cieśla, M., Szade, A., Szade, K., Bidanel, R., Langrzyk, A., Grochowski, R., Vandermeeren, F., et al. (2018) · IUBMB Life · doi:10.1002/iub.1711 · Cited by 21
p16 Controls p53 Protein Expression Through miR-dependent Destabilization of MDM2
Al‐Khalaf, H. H., & Aboussekhra, A. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0017 · Cited by 22
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
Xu, Y., Nasri, M., Dannenmann, B., Mir, P., Zahabi, A., Welte, K., Morishima, T., & Skokowa, J. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02144-9 · Cited by 21
Clinical manifestations of combined factor V and VIII deficiency: A series of 37 cases from a single center in India
Viswabandya, A., Baidya, S., Nair, S. C., Lakshmi, K. M., Mathews, V., George, B., Chandy, M., & Srivastava, A. (2010) · American Journal of Hematology · doi:10.1002/ajh.21741 · Cited by 21
Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses
Iacovides, D. C., Michael, S., Achilleos, C., & Strati, K. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00066 · Cited by 21
Direct reprogramming 101
Takahashi, K. (2010) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2010.01169.x · Cited by 20
Self-citation
Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells
Naik, P. P., Panigrahi, S., Parida, R., Praharaj, P. P., Bhol, C. S., Patil, S., Manjunath, N., Ghosh, D., Patra, S. K., & Bhutia, S. K. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10216-9 · Cited by 20
Injury primes mutation-bearing astrocytes for dedifferentiation in later life
Ragdale, H. S., Clements, M., Tang, W., Deltcheva, E. M., Andreassi, C., Lai, A. G., Chang, W. H., Pandrea, M., Andrew, I., Gamé, L., et al. (2023) · Current Biology · doi:10.1016/j.cub.2023.02.013 · Cited by 20
Replication stress in mammalian embryo development, differentiation, and reprogramming
Wang, N., Xu, S., & Egli, D. M. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.015 · Cited by 21
Gene Signature of Human Oral Mucosa Fibroblasts: Comparison with Dermal Fibroblasts and Induced Pluripotent Stem Cells
Miyoshi, K., Horiguchi, T., Tanimura, A., Hagita, H., & Noma, T. (2015) · BioMed Research International · doi:10.1155/2015/121575 · Cited by 21
Practical Integration‐Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells
Kime, C., Rand, T., Ivey, K. N., Srivastava, D., Yamanaka, S., & Tomoda, K. (2015) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg2102s87 · Cited by 20
Self-citation
Induced Pluripotent Stem Cells: A New Approach for Physiological Research
Pfannkuche, K., Hannes, T., Khalil, M., Noghabi, M. S., Morshedi, A., Hescheler, J., & Dröge, P. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000320514 · Cited by 21
Therapeutic opportunities: Telomere maintenance in inducible pluripotent stem cells
Gourronc, F. A., & Klingelhutz, A. J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.05.008 · Cited by 20
Genome integrity: linking pluripotency and tumorgenicity
Deng, W., & Xu, Y. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.09.004 · Cited by 20
Suppression of Lefty expression in induced pluripotent cancer cells
Saito, A. M., Ochiai, H., Okada, S., Miyata, N., & Azuma, T. (2013) · The FASEB Journal · doi:10.1096/fj.12-221432 · Cited by 20
Valproic acid assisted reprogramming of fibroblasts for generation of pluripotent stem cells in buffalo (Bubalus bubalis)
Mahapatra, P. S., Singh, R., Kumar, K., Sahoo, N. R., Agarwal, P., Mili, B., Das, K., Sarkar, M., BHANJA, S. K., Das, B. C., et al. (2016) · The International Journal of Developmental Biology · doi:10.1387/ijdb.160006sb · Cited by 20
OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates
Kagawa, H., Shimamoto, R., Kim, S., Oceguera-Yañez, F., Yamamoto, T., Schroeder, T., & Woltjen, K. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.008 · Cited by 20
Identification of potential transcription factors that enhance human iPSC generation
Swaidan, N. T., Salloum‐Asfar, S., Palangi, F., Errafii‬, K., Soliman, N., Aboughalia, A. T., Saidwali, A. H., Abdulla, S. A., & Emara, M. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-78932-9 · Cited by 20
AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts
Xu, H., Zhou, Y., Coughlan, K. A., Ding, Y., Wang, S., Wu, Y., Song, P., & Zou, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.002 · Cited by 21
Roles of p53 in Various Biological Aspects of Hematopoietic Stem Cells
Nii, T., Marumoto, T., & Tani, K. (2012) · BioMed Research International · doi:10.1155/2012/903435 · Cited by 21
Direct regulation of p53 by miR-142a-3p mediates the survival of hematopoietic stem and progenitor cells in zebrafish
Lu, X., Wei, Y., & Liu, F. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.27 · Cited by 21
Innovation for hepatotoxicity in vitro research models: A review
Han, W., Wu, Q., Zhang, X., & Duan, Z. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3711 · Cited by 22
CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells
Zheng, Z. S., Li, C., Ha, P., Chang, G. X., Yang, P., Zhang, X., Kim, J. K., Jiang, W., Pang, X., Berthiaume, E. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125015 · Cited by 20
Efficient Generation of Induced Pluripotent Stem Cells from Human Bone Marrow Mesenchymal Stem Cells
Yulin, X., Lizhen, L., Lifei, Z., Shan, F., Ru, L., Kaimin, H., & Huang, H. (2012) · Folia Biologica · doi:10.14712/fb2012058060221 · Cited by 20
Miat and interacting protein Metadherin maintain a stem-like niche to promote medulloblastoma tumorigenesis and treatment resistance
Peng, K.-L., Vasudevan, H. N., Lockney, D. T., Baum, R., Hendrickson, R. C., Raleigh, D. R., & Schmitt, A. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203738119 · Cited by 19
B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors
Kaemena, D. F., Yoshihara, M., Beniazza, M., Ashmore, J., Zhao, S., Bertenstam, M., Olariu, V., Katayama, S., Okita, K., Tomlinson, S. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36097-9 · Cited by 20
Self-citation
Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells
Lin, Y., Ku, C., Wuputra, K., Liu, C., Wu, D., Satou, M., Mitsui, Y., Saito, S., & Yokoyama, K. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105177 · Cited by 21
Telomere Biology in Stem Cells and Reprogramming
Batista, L. F. Z. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00003-7 · Cited by 22
Advances and applications of induced pluripotent stem cells
Pietronave, S., & Prat, M. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-125 · Cited by 19
Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality
Cao, S., Loh, K. M., Pei, Y., Zhang, W., & Han, J. (2012) · Protein & Cell · doi:10.1007/s13238-012-2078-6 · Cited by 19
Acute reduction in oxygen tension enhances the induction of neurons from human fibroblasts
Davila, J., Chanda, S., Ang, C. E., Südhof, T. C., & Wernig, M. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.03.020 · Cited by 19
Informational needs assessment of non‐Hodgkin lymphoma survivors and their physicians
Friedman, D. R., Sykes, A. D., Smith, S. K., Herndon, J. E., & Abernethy, A. P. (2010) · American Journal of Hematology · doi:10.1002/ajh.21725 · Cited by 19
Transcriptomes and shRNA Suppressors in a TP53 Allele–Specific Model of Early-Onset Colon Cancer in African Americans
Weige, C. C., Birtwistle, M. R., Mallick, H., Yi, N., Berrong, Z., Cloessner, E., Duff, K., Tidwell, J. A., Clendenning, M., Wilkerson, B. J., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0286-t · Cited by 19
Long non-coding RNAs involved in the regulatory network during porcine pre-implantation embryonic development and iPSC induction
Zhong, L., Mu, H., Wen, B., Zhang, W., Wei, Q., Gao, G., Han, J., & Cao, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-24863-5 · Cited by 19
miR‑125a is upregulated in cancer stem‑like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53
Chen, J., Ouyang, H., An, X., & Liu, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9587 · Cited by 19
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 19
HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells
Kwon, Y., Ahn, H.-S., Lee, J. W., Yang, H., Cho, H., Kim, S. J., Lee, S.-H., Yang, H.-M., Jang, H.-D., Kim, S. J., et al. (2021) · Stem Cells International · doi:10.1155/2021/8873383 · Cited by 19
Responsiveness to perturbations is a hallmark of transcription factors that maintain cell identity in vitro
Mellis, I. A., Edelstein, H. I., Truitt, R., Goyal, Y., Beck, L. E., Symmons, O., Dunagin, M. C., Linares-Saldana, R., Shah, P. P., Pérez-Bermejo, J. A., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.07.003 · Cited by 20
Somatic Reprogramming—Above and Beyond Pluripotency
Meir, Y. J., & Li, G. (2021) · Cells · doi:10.3390/cells10112888 · Cited by 19
DNA Damage during G2 Phase Does Not Affect Cell Cycle Progression of the Green Alga Scenedesmus quadricauda
Hlavová, M., Čížková, M., Vítová, M., Bišová, K., & Zachleder, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019626 · Cited by 19
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
Hubbard, J. J., Sullivan, S. K., Mills, J. A., Hayes, B. J., Torok‐Storb, B., & Ramakrishnan, A. (2014) · Journal of Visualized Experiments · doi:10.3791/52009 · Cited by 19
Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells
Phanthong, P., Raveh-Amit, H., Li, T., Kitiyanant, Y., & Dinnyés, A. (2013) · Biogerontology · doi:10.1007/s10522-013-9455-2 · Cited by 19
Impacts of and interactions between environmental stress and epigenetic programming during early embryo development
Bertoldo, M. J., Locatelli, Y., O’Neill, C., & Mermillod, P. (2014) · Reproduction Fertility and Development · doi:10.1071/rd14049 · Cited by 19
Enhanced O-GlcNAc modification induced by the RAS/MAPK/CDK1 pathway is required for SOX2 protein expression and generation of cancer stem cells
Shimizu, M., Shibuya, H., & Tanaka, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-06916-y · Cited by 18
Induced Pluripotent Stem Cells
Zaehres, H., Kim, J. B., & Schöler, H. R. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)76018-3 · Cited by 18
The role of p53 in limiting somatic cell reprogramming
Liu, Y., Hoya-Arias, R., & Nimer, S. D. (2009) · Cell Research · doi:10.1038/cr.2009.121 · Cited by 18
Late Passage Human Fibroblasts Induced to Pluripotency Are Capable of Directed Neuronal Differentiation
Liu, J., Sümer, H., Leung, J., Upton, K. R., Dottori, M., Pébay, A., & Verma, P. J. (2010) · Cell Transplantation · doi:10.3727/096368910x514305 · Cited by 18
Generation of Genome Integration-free Induced Pluripotent Stem Cells from Fibroblasts of C57BL/6 Mice without c-Myc Transduction
Jincho, Y., Araki, R., Hoki, Y., Tamura, C., Nakamura, M., Ando, S., Kasama, Y., & Abe, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115915 · Cited by 18
Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
Oh, S.-I., Lee, C. K., Cho, K. J., Lee, K.-O., Cho, S., & Hong, S. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/417809 · Cited by 18
Enhanced proliferation in colorectal epithelium of patients with type 2 diabetes correlates with β-catenin accumulation
Li, J., Yu, T., Xia, Z., Chen, G.-C., Yuan, Y., Zhong, W., Zhao, L., & Chen, Q. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.05.001 · Cited by 19
Role of Rho kinases in abnormal and normal hematopoiesis
Mali, R. S., Kapur, S., & Kapur, R. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000056 · Cited by 18
Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies
Kohno, S., Kitajima, S., Sasaki, N., & Takahashi, C. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i4.170 · Cited by 18
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
Grespi, F., Landré, V., Molchadsky, A., Daniele, N. D., Marsella, L., Melino, G., & Rotter, V. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.419 · Cited by 18
The Role of Existing and Emerging Biotechnologies for Livestock Production: toward holism
Wheeler, M. B., Monaco, E. L., Bionaz, M., & Tanaka, T. S. (2010) · ACTA SCIENTIAE VETERINARIAE · Cited by 18
BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
Kim, E. J. Y., Änkö, M., Flensberg, C., Majewski, I. J., Geng, F., Firas, J., Huang, D. C. S., van Delft, M. F., & Heath, J. K. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.019 · Cited by 19
Highly efficient induction of primate iPS cells by combining RNA transfection and chemical compounds
Watanabe, T., Yamazaki, S., Yoneda, N., Shinohara, H., Tomioka, I., Higuchi, Y., Yagoto, M., Ema, M., Suemizu, H., Kawai, K., et al. (2019) · Genes to Cells · doi:10.1111/gtc.12702 · Cited by 19
Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes
Allen, J. E., Hart, L. S., Dicker, D. T., Wang, W., & El‐Deiry, W. S. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.22.10450 · Cited by 18
The H2B ubiquitin-protein ligase RNF40 is required for somatic cell reprogramming
Xie, W., Miehe, M., Laufer, S. D., & Johnsen, S. A. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2482-4 · Cited by 19
Reprogramming and transdifferentiation - two key processes for regenerative medicine
Hybiak, J., Jankowska, K., Machaj, F., Rosik, J., Broniarek, I., Żyluk, A., Hilderman, G. C., Małecki, A., Łoś, M., & Urasińska, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173202 · Cited by 20
The Cell Biology of Stem Cells
Meshorer, E., & Plath, K. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4 · Cited by 20
Role of small molecules as drug candidates for reprogramming somatic cells into induced pluripotent stem cells: A comprehensive review
Rehman, A., Fatima, I., Noor, F., Qasim, M., Wang, P., jia, J., Alshabrmi, F. M., & Liao, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108661 · Cited by 17
Concise Review: Induced Pluripotency by Defined Factors: Prey of Oxidative Stress
Qi, S., Fang, Z. H., Wang, D., Menéndez, P. R., Yao, K., & Ji, J. (2015) · Stem Cells · doi:10.1002/stem.1946 · Cited by 17
Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes
Yan, X., Lv, A., Xing, Y., Liu, B., Hou, J., Huang, W. C., & Li, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0801-x · Cited by 17
The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential
Iglesias, J. M., Leis, O., Ruiz, E. P., Barrie, J. G., Garcia‐García, F., Aduriz, A., Beloqui, I., Hernández-García, S., Lopez-Mato, M. P., Dopazo, J., et al. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00308 · Cited by 18
Strategies to produce hepatocytes and hepatocyte‐like cells from pluripotent stem cells
Chistiakov, D. A., & Chistiakov, P. A. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00896.x · Cited by 17
RNA Genes: Retroelements and Virally Retroposable microRNAs in Human Embryonic Stem Cells~!2010-01-14~!2010-04-20~!2010-05-25~!
Fujii, Y. R. (2010) · The Open Virology Journal · doi:10.2174/1874357901004010063 · Cited by 18
TRIM32 modulates pluripotency entry and exit by directly regulating Oct4 stability
Bahnassawy, L., Perumal, T. M., González-Cano, L., Hillje, A., Taher, L., Makałowski, W., Suzuki, Y., Fuellen, G., del Sol, A., & Schwamborn, J. C. (2015) · Scientific Reports · doi:10.1038/srep13456 · Cited by 17
Safe Transplantation Of Pluripotent Stem Cell By Preventing Teratoma Formation
Mohseni, R. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000212 · Cited by 17
Epigenetics of Solid Cancer Stem Cells
Mishra, A., & Verma, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-612-8_2 · Cited by 17
Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology
Sogabe, Y., Seno, H., Yamamoto, T., & Yamada, Y. (2018) · Cancer Science · doi:10.1111/cas.13731 · Cited by 17
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
Bailly, A., Milhavet, O., & Lemaı̂tre, J.-M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020317 · Cited by 18
Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming
Xi, C., Sun, J., Xu, X., Wu, Y., Kou, X., Zhao, Y., Shen, J., Dong, Y., Chen, K., Su, Z., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.06.012 · Cited by 17
Molecular mechanisms of pluripotency and reprogramming
Na, J., Plews, J. R., Li, J., Wongtrakoongate, P., Tuuri, T., Féki, A., Andrews, P. W., & Unger, C. A. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt33 · Cited by 18
Induced pluripotent stem cells – alchemist's tale or clinical reality?
Rashid, S. T., & Vallier, L. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001596 · Cited by 17
Indispensable role of Mdm2/p53 interaction during the embryonic and postnatal inner ear development
Laos, M., Sulg, M., Herranen, A., Anttonen, T., & Pirvola, U. (2017) · Scientific Reports · doi:10.1038/srep42216 · Cited by 17
Oocyte-Specific Homeobox 1, Obox1, Facilitates Reprogramming by Promoting Mesenchymal-to-Epithelial Transition and Mitigating Cell Hyperproliferation
Wu, L., Wu, Y., Peng, B., Hou, Z., Dong, Y., Chen, K., Guo, M., Li, H., Chen, X., Kou, X., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.012 · Cited by 17
NANOG: A promising target for digestive malignant tumors
Sun, A.-X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.13071 · Cited by 16
Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion
Kwon, D., Ji, M., Lee, S., Seo, K. W., & Kang, K. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9697-x · Cited by 16
The Cyclin-Like Protein SPY1 Overrides Reprogramming Induced Senescence Through EZH2 Mediated H3K27me3
Lubanska, D., Qemo, I., Byrne, M., Matthews, K. N., Fifield, B., Brown, J. R., da Silva, E. F., & Porter, L. A. (2021) · Stem Cells · doi:10.1002/stem.3453 · Cited by 16
Recognizing the Binding Pattern and Dissociation Pathways of the p300 Taz2-p53 TAD2 Complex
Li, T., Motta, S., Stevens, A. O., Song, S., Hendrix, E., Pandini, A., & He, Y. J. (2022) · JACS Au · doi:10.1021/jacsau.2c00358 · Cited by 16
Two distinct knockout approaches highlight a critical role for p53 in rat development
Kawamata, M., & Ochiya, T. (2012) · Scientific Reports · doi:10.1038/srep00945 · Cited by 16
The genomic stability of induced pluripotent stem cells
Chen, Z., Zhao, T., & Xu, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2922-8 · Cited by 16
A population of BJ fibroblasts escaped from Ras-induced senescence susceptible to transformation
Kohsaka, S., Sasai, K., Takahashi, K., Akagi, T., Tanino, M. A., Kimura, T., Nishihara, H., & Tanaka, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.082 · Cited by 18
Self-citation
Choreographing pluripotency and cell fate with transcription factors
Gonzales, K. A. U., & Ng, H. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.06.009 · Cited by 17
Cyclin A 1 Is Essential for Setting the Pluripotent State and Reducing Tumorigenicity of Induced Pluripotent Stem Cells
McLenachan, S., Menchón, C., Raya, Á., Consiglio, A., & Edel, M. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0190 · Cited by 16
Current Reprogramming Systems in Regenerative Medicine: From Somatic Cells to Induced Pluripotent Stem Cells
Hu, C., & Li, L. (2015) · Regenerative Medicine · doi:10.2217/rme.15.79 · Cited by 17
Cancer stem cells in relation to treatment
Miyoshi, N., Mizushima, T., Doki, Y., & Mori, M. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy186 · Cited by 17
Palmitic Acid Methyl Ester Induces G2/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway
Lin, J., Ting, P., Lee, W., Chiu, H.-W., Chien, C.-A., Liu, C., Sun, L., & Yang, K. (2019) · Stem Cells International · doi:10.1155/2019/7606238 · Cited by 16

Authors: Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S.
Affiliations: Kyoto University (JP)
RIKEN (JP)
Gladstone Institutes (US)
Corresponding author: Yamanaka, Shinya
ORCID: Takahashi, Kazutoshi
Aoi, Takashi
Kanagawa, Osami
Nakagawa, Masato
Okita, Keisuke
Yamanaka, Shinya
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-08
Volume: 460
Issue: 7259
Pages: 1132-1135
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08235
PMC: PMC2917235
OpenAlex: W2081620485
Cited by: 1,301
References: 23
Citations by year: 2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 44 · 2021: 51 · 2020: 41 · 2019: 56 · 2018: 63 · 2017: 59 · 2016: 78 · 2015: 88 · 2014: 116 · 2013: 117 · 2012: 168
FWCI: 67.71
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (U01HL100406)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: induced pluripotent stem cells, p53, p21, p53/p21 pathway, reprogramming efficiency, mouse embryonic fibroblasts, T cells, plasmid transfection, p53 target genes, tumorigenicity, Oct4, SOX2, KLF4, c-Myc
MeSH terms: Kruppel-Like Factor 4, Adult, Animals, Cell Differentiation, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Plasmids, T-Lymphocytes, Transfection, Tumor Suppressor Protein p53, Genes, myc, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks